1. Home
  2. XBIO vs BQ Comparison

XBIO vs BQ Comparison

Compare XBIO & BQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XBIO
  • BQ
  • Stock Information
  • Founded
  • XBIO N/A
  • BQ 2008
  • Country
  • XBIO United States
  • BQ China
  • Employees
  • XBIO N/A
  • BQ N/A
  • Industry
  • XBIO Biotechnology: Pharmaceutical Preparations
  • BQ Other Specialty Stores
  • Sector
  • XBIO Health Care
  • BQ Consumer Discretionary
  • Exchange
  • XBIO Nasdaq
  • BQ Nasdaq
  • Market Cap
  • XBIO 6.3M
  • BQ 5.7M
  • IPO Year
  • XBIO N/A
  • BQ 2020
  • Fundamental
  • Price
  • XBIO $4.06
  • BQ $0.30
  • Analyst Decision
  • XBIO Hold
  • BQ
  • Analyst Count
  • XBIO 1
  • BQ 0
  • Target Price
  • XBIO N/A
  • BQ N/A
  • AVG Volume (30 Days)
  • XBIO 22.9K
  • BQ 193.0K
  • Earning Date
  • XBIO 11-12-2024
  • BQ 12-31-2024
  • Dividend Yield
  • XBIO N/A
  • BQ N/A
  • EPS Growth
  • XBIO N/A
  • BQ N/A
  • EPS
  • XBIO N/A
  • BQ N/A
  • Revenue
  • XBIO $2,523,427.00
  • BQ $98,241,396.00
  • Revenue This Year
  • XBIO N/A
  • BQ N/A
  • Revenue Next Year
  • XBIO N/A
  • BQ N/A
  • P/E Ratio
  • XBIO N/A
  • BQ N/A
  • Revenue Growth
  • XBIO 7.15
  • BQ N/A
  • 52 Week Low
  • XBIO $2.78
  • BQ $0.22
  • 52 Week High
  • XBIO $5.20
  • BQ $0.74
  • Technical
  • Relative Strength Index (RSI)
  • XBIO 47.20
  • BQ 30.17
  • Support Level
  • XBIO $3.92
  • BQ $0.32
  • Resistance Level
  • XBIO $4.27
  • BQ $0.38
  • Average True Range (ATR)
  • XBIO 0.27
  • BQ 0.04
  • MACD
  • XBIO -0.05
  • BQ -0.01
  • Stochastic Oscillator
  • XBIO 19.09
  • BQ 0.00

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.

About BQ Boqii Holding Limited representing

Boqii Holding Ltd operates in the business of selling pet products through online stores. The store provides pet foods, health products, pet grooming products, pet bathing products, pet toys, fish tank, aquatic fertilizer, temperature control equipment, oxygen pump and other related products. Also, the company sells its products through offline channels to pet stores and hospitals.

Share on Social Networks: